Exane Derivatives’s Sinclair Inc SBGI Stock Holding History

Exane Derivatives’s Portfolio SBGI Stock Details SBGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1	Closed	-$38	–	709
2019 Q1	$38	Sell	1 -16	-94%	-$536	﹤0.01%	603
2018 Q4	$448	Sell	17 -5,600	-100%	-$163K	﹤0.01%	611
2018 Q3	$159K	Buy	+5,617	New	+$160K	0.03%	267

Other funds holding SBGI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Exane Derivatives's SBGI Position: Q2 2019 in Review

Exane Derivatives sold out of Sinclair Inc (SBGI) in Q2 2019, closing a stake of 1 share — an estimated $38 sold.

Exane Derivatives first reported a position in SBGI in Q3 2018 and held it in 3 quarters. The position peaked at $159K in Q3 2018. 277 funds tracked by Wall St. Rank hold SBGI as of Q2 2019.

Exane Derivatives reported no remaining Sinclair Inc position as of Q2 2019 after selling out during the quarter.
Exane Derivatives sold 1 Sinclair Inc share in Q2 2019, an estimated $38.
Exane Derivatives first reported a position in Sinclair Inc in Q3 2018 and held it in 3 quarters.
Exane Derivatives's Sinclair Inc position peaked at $159K in Q3 2018.
277 funds tracked by Wall St. Rank held Sinclair Inc as of Q2 2019.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.